FDA Grants EUA To Vilobelimab For COVID-19 Treatment In Critically-Ill Adults

Bloomberg Law (4/4, Bañares, Subscription Publication) reports, “InflaRx said the US FDA has granted Emergency Use Authorization to Gohibic (vilobelimab) for the treatment of Covid-19 in critically-ill adults.” The agency “granted EUA based on Phase 3 cli...